DGCI

Govt Panel Nod To Zydus Cadila's 3-dose COVID Vaccine ZyCov-D

It showed an efficacy rate of 66.6% in a late-stage trial of more than 28,000 volunteers nationwide. It also said the vaccine is safe for children between 12 and 18 years of age.